In Section A, contributors will receive unique doses and schedules of oral ABBV-744 pill to recognize Harmless dosing regimen. Additional members will be enrolled with the determined monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "include-on" therapy. In Section C, members https://abbv-744inthetreatmentofd68945.blogdal.com/32366910/the-2-minute-rule-for-is-abbv-744-effective-for-hematologic-cancers